Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 19 | 2024 | 879 | 3.320 |
Why?
|
| Peritoneal Dialysis | 9 | 2024 | 117 | 2.500 |
Why?
|
| Renal Dialysis | 14 | 2024 | 852 | 1.550 |
Why?
|
| Catheters, Indwelling | 4 | 2024 | 154 | 1.270 |
Why?
|
| Catheter-Related Infections | 6 | 2024 | 128 | 1.050 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 727 | 1.010 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 2 | 2020 | 20 | 0.830 |
Why?
|
| Hydrothorax | 1 | 2020 | 11 | 0.690 |
Why?
|
| Calcimimetic Agents | 1 | 2019 | 5 | 0.670 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 14 | 0.660 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 643 | 0.510 |
Why?
|
| Renal Insufficiency | 4 | 2024 | 236 | 0.480 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2019 | 54 | 0.450 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2014 | 82 | 0.430 |
Why?
|
| Latent Tuberculosis | 1 | 2014 | 74 | 0.430 |
Why?
|
| Child | 26 | 2024 | 24375 | 0.430 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2022 | 101 | 0.350 |
Why?
|
| Catheterization | 3 | 2022 | 234 | 0.320 |
Why?
|
| Renal Replacement Therapy | 3 | 2023 | 142 | 0.320 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2023 | 81 | 0.320 |
Why?
|
| Nephrosis, Lipoid | 1 | 2009 | 11 | 0.310 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 48 | 0.310 |
Why?
|
| Cost Savings | 1 | 2008 | 71 | 0.300 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 212 | 0.300 |
Why?
|
| Infant | 11 | 2024 | 12469 | 0.280 |
Why?
|
| Oxygen | 2 | 2021 | 553 | 0.280 |
Why?
|
| Ascitic Fluid | 2 | 2017 | 30 | 0.280 |
Why?
|
| Child, Preschool | 12 | 2024 | 14009 | 0.270 |
Why?
|
| Humans | 35 | 2024 | 124596 | 0.270 |
Why?
|
| Adolescent | 17 | 2024 | 19280 | 0.260 |
Why?
|
| Hypertension | 2 | 2019 | 1320 | 0.250 |
Why?
|
| Health Care Costs | 1 | 2008 | 371 | 0.250 |
Why?
|
| Retrospective Studies | 12 | 2023 | 16314 | 0.240 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 636 | 0.230 |
Why?
|
| Peritonitis | 2 | 2024 | 75 | 0.230 |
Why?
|
| Observer Variation | 1 | 2024 | 299 | 0.210 |
Why?
|
| Pruritus | 1 | 2023 | 41 | 0.210 |
Why?
|
| Male | 21 | 2024 | 61192 | 0.210 |
Why?
|
| Kidney | 3 | 2023 | 1358 | 0.200 |
Why?
|
| Oximetry | 2 | 2021 | 162 | 0.200 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2022 | 27 | 0.190 |
Why?
|
| Ureteral Obstruction | 1 | 2023 | 105 | 0.190 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 57 | 0.190 |
Why?
|
| Ureter | 1 | 2023 | 97 | 0.190 |
Why?
|
| Brain Chemistry | 1 | 2021 | 124 | 0.180 |
Why?
|
| Standard of Care | 2 | 2019 | 130 | 0.180 |
Why?
|
| Hematocrit | 1 | 2020 | 111 | 0.170 |
Why?
|
| Female | 16 | 2024 | 66485 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 270 | 0.170 |
Why?
|
| Blood | 1 | 2020 | 104 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 56 | 0.170 |
Why?
|
| Veins | 1 | 2020 | 107 | 0.170 |
Why?
|
| Infant Formula | 1 | 2020 | 97 | 0.160 |
Why?
|
| Venous Thrombosis | 2 | 2019 | 183 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2019 | 380 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 103 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 390 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8190 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 109 | 0.150 |
Why?
|
| Bacteremia | 1 | 2022 | 407 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 130 | 0.150 |
Why?
|
| Arterial Pressure | 1 | 2019 | 102 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 302 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 128 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 365 | 0.150 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 72 | 0.150 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 73 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 506 | 0.150 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 9 | 0.150 |
Why?
|
| Sevelamer | 1 | 2017 | 10 | 0.140 |
Why?
|
| Chelating Agents | 1 | 2017 | 42 | 0.140 |
Why?
|
| Hyperphosphatemia | 1 | 2017 | 17 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2021 | 321 | 0.140 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.140 |
Why?
|
| Milk, Human | 1 | 2020 | 299 | 0.140 |
Why?
|
| Chylous Ascites | 1 | 2017 | 11 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 503 | 0.140 |
Why?
|
| Heart | 1 | 2021 | 708 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12322 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 141 | 0.130 |
Why?
|
| Peritoneum | 1 | 2016 | 37 | 0.130 |
Why?
|
| Texas | 3 | 2017 | 3583 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 221 | 0.130 |
Why?
|
| Quality of Life | 2 | 2023 | 1916 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2019 | 640 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 125 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 10270 | 0.120 |
Why?
|
| Sepsis | 1 | 2019 | 478 | 0.120 |
Why?
|
| Nephrology | 1 | 2016 | 145 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 154 | 0.110 |
Why?
|
| Skin Tests | 1 | 2014 | 78 | 0.110 |
Why?
|
| Young Adult | 5 | 2019 | 9014 | 0.110 |
Why?
|
| Hyperammonemia | 1 | 2013 | 62 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 949 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 662 | 0.090 |
Why?
|
| Pediatrics | 2 | 2019 | 1164 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2014 | 480 | 0.090 |
Why?
|
| Incidence | 1 | 2018 | 3138 | 0.090 |
Why?
|
| Transplant Recipients | 2 | 2022 | 216 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2009 | 4795 | 0.080 |
Why?
|
| Glomerular Mesangium | 1 | 2009 | 19 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 737 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5145 | 0.080 |
Why?
|
| Cyclosporine | 1 | 2009 | 146 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 457 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2008 | 106 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 320 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 429 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 361 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 29438 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 2818 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2009 | 217 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 418 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 510 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2891 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3153 | 0.060 |
Why?
|
| Biopsy | 1 | 2009 | 1237 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 647 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 770 | 0.050 |
Why?
|
| Nitrogen | 1 | 2024 | 146 | 0.050 |
Why?
|
| United States | 1 | 2018 | 10887 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3424 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 242 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 34 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2024 | 314 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 111 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 103 | 0.050 |
Why?
|
| Blood Volume | 1 | 2021 | 80 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 6135 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 83 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2019 | 18 | 0.040 |
Why?
|
| Graft Survival | 1 | 2022 | 536 | 0.040 |
Why?
|
| Renal Veins | 1 | 2019 | 36 | 0.040 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 39 | 0.040 |
Why?
|
| Iliac Vein | 1 | 2019 | 34 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 487 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2019 | 46 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2019 | 68 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 46 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 173 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 191 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2022 | 590 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 432 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 333 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 194 | 0.040 |
Why?
|
| Arteries | 1 | 2019 | 221 | 0.040 |
Why?
|
| Iohexol | 1 | 2017 | 20 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2019 | 442 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1322 | 0.040 |
Why?
|
| Triiodobenzoic Acids | 1 | 2017 | 28 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2021 | 848 | 0.030 |
Why?
|
| Nephrology Nursing | 1 | 2016 | 2 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 29 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 78 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 236 | 0.030 |
Why?
|
| Myocardium | 1 | 2021 | 997 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 481 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 748 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1052 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2154 | 0.030 |
Why?
|
| Aorta | 1 | 2019 | 539 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 603 | 0.030 |
Why?
|
| Thrombosis | 1 | 2019 | 520 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 575 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 356 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1014 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 471 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 555 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 728 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1605 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 832 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1268 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 542 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 996 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 816 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1882 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 606 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3063 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2016 | 495 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2634 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3065 | 0.010 |
Why?
|